Arterial Hypertension and Renal Allograft Survival

Authors:
  • BCBorut Cizman
    Borut Cizman
  • MJMarshall Joffe
    Marshall Joffe
  • HFHarold I. Feldman
    Harold I. Feldman

Abstract
Renal transplantation has emerged as the treatment of choice for many patients with end-stage renal disease.1 However, despite marked improvements in short-term allograft function with administration of newer potent immunosuppressive medications, long-term allograft survival continues to be inadequate, with allograft failure being one of the most important reasons for (re)initiating long-term dialysis treatment in the United States.

This publication has 9 references indexed in Scilit: